Thats exactly what we focus on at InjectCo
Oral GLP-1s simplify distribution and patient access but cause significantly greater complexity upstream in the value chain, creating a distinct set of operational challenges
You may be at higher risk for this side effect if you already have kidney problems (such as chronic kidney disease)
Some individuals also experience modest improvements in their blood sugar levels, especially if using semaglutide for diabetes management
GLP-1 medications, by contrast, may face supply shortages, require specialty pharmacy fulfillment, and involve navigating prior authorization processes that can delay treatment by weeks
This was believed to be through an effect on g-aminobutyric acid (GABA) metabolism, particularly since valproic acid partly resembles GABA chemically in being a small, aliphatic acid (2-propylpentanoic acid